A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
4-Hexylresorcinol inhibits transglutaminase-2 activity and has synergistic effects along with cisplatin in KB cells
2011
Oncology Reports
resistance to chemotherapy is very important in the prognosis of tumors. transglutaminase-2 (tg-2) mediated chemotherapy resistance has been widely reported. the objective of this study was to demonstrate the effect of 4-hexylresorcinol (4-Hr) on tg-2 activity in nasopharyngeal squamous cell carcinoma cells (KB cells). treatment with a mixture of 4-HR and cisplatin significantly decreased KB cell viability compared to treatment by cisplatin alone at 10 µg/ml (p<0.001). 4-Hr inhibited tg-2
doi:10.3892/or.2011.1218
pmid:21424127
fatcat:joxjaowg4ncnti7pqakmkch2ou